Hindustan Bio Sciences Limited (HINDBIO.BO)
INR 10.5
(-3.85%)
INR 10.5
(-3.85%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -754.88 Thousand | -497.69 Thousand | -3.11 Million | 5.58 Million | 8.21 Million | -13.24 Million |
| Net Income | 575.94 Thousand | -404.53 Thousand | -5.17 Million | -9.39 Million | 808.72 Thousand | 1.09 Million |
| Depreciation & Amortization | 68.49 Thousand | 56.56 Thousand | 34.11 Thousand | 80.4 Thousand | 113.77 Thousand | 107.42 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.35 Million | -174.76 Thousand | -280.19 Thousand | 14.88 Million | 7.11 Million | -14.46 Million |
| Other non-cash items | 613.4 Thousand | 2.68 Million | 2.71 Million | -6.98 Million | -6.42 Million | 14.16 Million |
| Investing Cash Flow | - | - | -34.74 Thousand | - | - | -107.64 Thousand |
| Investments in PPE | 754.88 Thousand | - | -34.74 Thousand | - | - | -121.64 Thousand |
| Acquisitions | - | - | - | - | - | 14 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1 Million | 501.8 Thousand | 3.07 Million | -7.38 Million | -8.08 Million | 15 Million |
| Debt repayment | -1 Million | -501.8 Thousand | -3.07 Million | -7.38 Million | -8.08 Million | -15 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 1.00 | 3.00 | 3.00 | 30 Million |
| Accounts receivables | 114.51 Thousand | -3.18 Million | 2.55 Million | 7.45 Million | 3.11 Million | -13.56 Million |
| Accounts payables | -633.46 Thousand | 636.44 Thousand | -2.89 Million | -3.7 Million | 5.98 Million | -22.28 Thousand |
| Inventory | - | - | - | 3.4 Million | -2.26 Million | -344.95 Thousand |
| Other working capital | -837.83 Thousand | 2.37 Million | 65.69 Thousand | 7.72 Million | 289.94 Thousand | -528.61 Thousand |
| Cash at beginning of period | 953.73 Thousand | 91.26 Thousand | 166.92 Thousand | 1.96 Million | 1.83 Million | 180.02 Thousand |
| Cash at end of period | 350.11 Thousand | 953.73 Thousand | 91.26 Thousand | 166.92 Thousand | 1.96 Million | 1.83 Million |
| Capital Expenditure | 754.88 Thousand | - | -34.74 Thousand | - | - | -121.64 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -603.62 Thousand | 862.46 Thousand | -75.66 Thousand | -1.79 Million | 133.23 Thousand | 1.65 Million |
| Free Cash Flow | - | -497.69 Thousand | -3.15 Million | 5.58 Million | 8.21 Million | -13.36 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 575.94 Thousand | 691 Thousand | 663 Thousand | -1.22 Million | -404.53 Thousand | 119 Thousand |
| Depreciation & Amortization | 68.49 Thousand | 13 Thousand | 13 Thousand | 13 Thousand | 56.56 Thousand | 25 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.35 Million | - | - | - | -174.76 Thousand | - |
| Other non-cash items | 613.4 Thousand | -13 Thousand | -13 Thousand | -13 Thousand | 2.68 Million | -25 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1 Million | - | - | - | 501.8 Thousand | - |
| Debt repayment | -1 Million | - | - | - | -501.8 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 114.51 Thousand | - | - | - | -3.18 Million | - |
| Accounts payables | -633.46 Thousand | - | - | - | 636.44 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -837.83 Thousand | - | - | - | 2.37 Million | - |
| Cash at beginning of period | 953.73 Thousand | 87 Thousand | -576 Thousand | 953.73 Thousand | 91.26 Thousand | 834.73 Thousand |
| Cash at end of period | 350.11 Thousand | 691 Thousand | 87 Thousand | -1.22 Million | 953.73 Thousand | 953.73 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -603.62 Thousand | 604 Thousand | 663 Thousand | -2.17 Million | 862.46 Thousand | 119 Thousand |
| Free Cash Flow | -754.88 Thousand | 691 Thousand | 663 Thousand | -1.22 Million | -497.69 Thousand | 119 Thousand |
INDO
603379
ABBN
5201
WTBA
KUAS